Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
ADCs
Biotech
Daiichi stops internal development of next-wave ADC
Daiichi management argued that the decision was not about the new mPBD platform but instead stems from “a business and portfolio perspective.”
Angus Liu
Feb 2, 2026 10:55am
4 trends driving biopharma M&A this year, per Bain
Jan 28, 2026 5:00pm
InduPro nabs 2nd Big Pharma deal with $950M Lilly pact
Jan 7, 2026 3:52pm
2 biotechs run out of road
Dec 17, 2025 11:38am
Pfizer pulls the plug on 11 programs
Nov 4, 2025 2:40pm
French antibody biotech draws in $122M for push to clinic
Oct 16, 2025 11:19am